SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-027460
Filing Date
2020-10-23
Accepted
2020-10-23 16:32:32
Documents
1
Period of Report
2020-10-22

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6787
  Complete submission text file 0001127602-20-027460.txt   8093
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address
Business Address
CAUSEY CHRISTOPHER (Reporting) CIK: 0001237334 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 201258071